Re: Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial.

Published

Other Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Inman, BA

Published Date

  • May 2006

Published In

Volume / Issue

  • 175 / 5

Start / End Page

  • 1960 -

PubMed ID

  • 16600806

Pubmed Central ID

  • 16600806

International Standard Serial Number (ISSN)

  • 0022-5347

Digital Object Identifier (DOI)

  • 10.1016/S0022-5347(05)00970-5

Language

  • eng

Conference Location

  • United States